Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

117.28
BATS BZX Real-Time Price
As of 3:12pm ET
 -0.49 / -0.42%
Today’s Change
102.50
Today|||52-Week Range
190.13
-25.11%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$5.2B

Company Description

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening cardiovascular and infectious diseases and cancer. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Contact Information

United Therapeutics Corp.
1040 Spring Street
Silver Spring Maryland 20910
P:(301) 608-9292
Investor Relations:

Employees

Shareholders

Other institutional66.22%
Mutual fund holders49.54%
Individual stakeholders13.65%

Top Executives

Martine A. RothblattChairman & Co-Chief Executive Officer
Roger A. JeffsPresident, Co-Chief Executive Officer & Director
David ZaccardelliChief Operating Officer & Executive Vice President
James Christopher EdgemondChief Financial Officer & Treasurer
Paul A. MahonSecretary, EVP & General Counsel